Molegro has released the latest version of Virtual Docker, an integrated platform for computational drug design available for Windows, Linux and Mac OS X
New versions of Molegro Virtual Docker (MVD), Molegro Molecular Viewer (MMV), and Molegro Data Modeller (MDM) have been released, all with support for the open-source KNIME (Konstanz Information Miner) platform
Molegro has released Molegro Data Modeller v2.5, a cross-platform application for data mining, data modelling and data visualisation
Molegro has updated Molegro Virtual Docker, its integrated platform for computation drug design available for Windows, Linux, and Mac OS X
Molegro has announced Molegro Data Modeller, a cross-platform application for data mining, data modelling and data visualisation
Molegro has released Molegro Data Modeller, a cross-platform application for data mining, data modelling, and data visualisation.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
